Prakt. lékáren. 2017; 13(4): 162-165 | DOI: 10.36290/lek.2017.022
Application devices in diabetic patients’ treatment
- Interní klinika 2. LF UK a FN v Motole, Praha
In the treatment of diabetic patients (suffering from type 1 and type 2 diabetes as well as from other types of diabetes) drugswhich must be administered via parenteral way are frequently used. These drugs are applied subcutaneously. To this group notonly insulin belongs. GLP-1 analogues and glucagon (e.g. an emergency medication for hypoglycaemic coma) are given subcutaneouslyas well. The administration of these drugs must be precise, gentle, simple and safe to prevent the risk of infection.Application devices used to deliver these drugs must fulfil these criteria but esthetical viewpoint should be taken into account aswell. These devices are disposable or not (e.g. can be used repeatedly). In this article, current status regarding needles and syringesused by diabetic patients as well as regarding insulin (or other application) pens and insulin pump is discussed. The analysis ofdevices intended for daily diabetic patients’ life enhancement is accompanied by the historical overview of their development.
Keywords: application device, diabetes, insulin, insulin pump, pen
Published: December 1, 2017 Show citation
References
- Kudlová P, Chlup R. Pomůcky k aplikaci inzulinu. Med. Pro Praxi 2006; 6: 298-301.
- Chlup R, Janů K, Menzel R, Bruns W, Venháčová J. Léčba diabetu pomocí ručního dávkovače inzulinu MADI. Univerzita Palackého v Olomouci, Olomouc, 1985; 64 s.
- Chlup R, Janů K, Venháčová J, Bartek J. Six models of a new insulin pen (MADI): description and first clinical trial. Practical Diabetes International 1995; 12(1): 32-35.
Go to original source... - Dvořáková L. Diabetes je záhadná nemoc aneb z historie diabetu. DiaInfo 2007; 45.
- SPC Humalog(R) 200 IU/ml, staženo 11. 8. 2017. http://www.ema.europa.eu/docs/cs_CZ/document_library/EPAR_-_Product_Information/human/000088/WC500050332.pdf
- SPC Toujeo(R) 300 IU/ml, staženo 11. 8. 2017. http://www.ema.europa.eu/docs/cs_CZ/document_library/EPAR_-_Product_Information/human/000309/WC500047935.pdf
- SPC Xultophy(R), staženo 11. 8. 2017 http://www.ema.europa.eu/docs/cs_CZ/document_library/EPAR_-_Product_Information/human/002647/WC500177657.pdf
- SPC NovoRapid(R) PumpCart(R), staženo 11. 8. 2017 http://www.ema.europa.eu/docs/cs_CZ/document_library/EPAR_-_Product_Information/human/000258/WC5
- Úhradový katalog VZP - ZP. Metodika (verze 992). Str. 48 https://webevzp.blob.core.windows.net/media/Default/dokumenty/ciselniky/metodika_992.pdf, staženo 2. 11. 2017
- Štechová K. Léčba inzulinovou pumpou. In: Štechová K (ed). Technologie v diabetologii. Maxdorf s. r. o. Praha 2016, 61-95.
- Glucagen 1 mg Hypokit SPC, staženo 11.8.2017 http://www.sukl.cz/modules/medication/detail.php?code=0083741&tab=texts
- Šmahelová A, Lášticová M. Diabetologie pro farmaceuty. Mladá Fronta Praha, 1. vydání, 2011.
- Aronson R, Gibney MA, Oza K, Bérubé J, Kassler-Taub K, Hirsch L. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings. Clin Ther. 2013; 35(7): 923-933. Go to original source...
Go to PubMed...